Current evidence suggest that nebulized heparin has shown some potential clinical benefits in patients with acute respiratory conditions, offering a more comfortable administration route, that may enhance patient compliance to the therapy without significantly increasing the bleeding risk. Nevertheless, further large-scale, well-designed clinical trials are necessary to fully establish the efficacy and safety of nebulized heparin across diverse patient populations
Nebulized heparin in 2025: at the interface between promising benefits and the need for further research
Lippi, Giuseppe
;
In corso di stampa
Abstract
Current evidence suggest that nebulized heparin has shown some potential clinical benefits in patients with acute respiratory conditions, offering a more comfortable administration route, that may enhance patient compliance to the therapy without significantly increasing the bleeding risk. Nevertheless, further large-scale, well-designed clinical trials are necessary to fully establish the efficacy and safety of nebulized heparin across diverse patient populations
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
